Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.

Area of Science:

• Immunology
• Structural Biology
• Computational Biology

Background:

• Macrophage migration inhibitory factor (MIF) is a critical cytokine in autoimmune and inflammatory diseases.
• MIF mediates its effects via the CD74 receptor, a component of MHC class II molecules.
• The precise spatial orientation of MIF-CD74 binding has remained elusive.

Purpose of the Study:

• To model the in silico binding interactions between MIF and its receptor CD74.
• To investigate the binding of a competitive MIF inhibitor, RTL1000, to CD74.
• To elucidate the structural basis of MIF-CD74 complex formation and antagonism.

Main Methods:

• Utilized in silico docking to model molecular interactions.
• Analyzed binding sites and residue interactions between MIF, CD74, and RTL1000.
• Predicted the stoichiometry and structure of the MIF-CD74 complex.

Main Results:

• Identified three binding sites on the MIF trimer for CD74 trimer binding.
• Each binding site involves interactions with two distinct 5-amino acid determinants.
• The antagonist RTL1000 utilizes the same binding determinants on CD74 as MIF.
• Predicted a novel dodecameric complex: MIF(CD74)3.

Conclusions:

• The structural model suggests a MIF(CD74)3 complex, potentially explaining enhanced MIF potency.
• The shared binding determinants for MIF and RTL1000 provide a basis for antagonism.
• The findings support the need for a ~3-fold excess of RTL1000 for effective antagonism.